Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Cardiac Sciences
    • 1-Hour Algorithm for...

    1-Hour Algorithm for diagnosis AMI by high-sensitivity troponin-BACC Trial

    Written by supriya kashyap kashyap Published On 2016-09-06T09:41:04+05:30  |  Updated On 6 Sept 2016 9:41 AM IST
    1-Hour Algorithm for diagnosis AMI by high-sensitivity troponin-BACC Trial

    Diagnosis of AMI in suspected patients of ACS is always a difficult issue for a clinician.


    This is so , especially when the diagnosis of AMI is necessitated with the diagnosis of Myocardial necrosis, it is necessary to diagnose the evidence as early as possible.


    Neumann and colleagues tested a 1-hour diagnostic algorithm to diagnose AMI using a high-sensitivity troponin I assay (hsTnI) with a new and lower cutoff level of 6ng/L.


    Biomarkers in Acute Cardiac Care (BACC trial) was a prospective study that tested an hsTnI assay for the 1-hour (versus standard 3-hour) diagnosis of AMI in 1040 patients (65% male, median age, 65 years) presenting to the emergency department with acute chest pain suggestive of AMI. The results were validated in 2 independent cohorts comprising 4,009 patients.


    Non-ST segment elevation myocardial infarction (NSTEMI) was diagnosed in 184 patients by measuring troponin T (using a standard assay) on presentation and after 3 hours, combined with clinical data, imaging, ECG and clinical judgment. Patients were assayed for hs-TnI at presentation and after 1 and 3 hours and followed for 6 months.


    Using a low hsTnI cutoff value of 6 ng/L, the rule-out algorithm showed a negative predictive value of 99.8% after 1 hour for NSTEMI type 1. Similarly, a rule-in algorithm based on troponin I levels provided a high positive predictive value with 82.8%. Also, the use of the 6 ng/L cutoff resulted in lower follow-up mortality (1.0%) compared with the routinely used 99th percentile (3.7%; p=0.001) for this assay. The findings were validated in 2 independent cohorts where the cutoff showed similarly high negative and positive predictive values. The 1-hour approach was statistically comparable to a 3-hour approach.


    The investigators concluded that patients with suspected AMI can be triaged within 1 hour of presentation to the emergency department with no loss of safety compared with a 3-hour approach, when a low and sensitive hsTnI cutoff is applied. This concept enables safe discharge or rapid treatment initiation after 1 hour.


    References




    • 1 Neumann JT, Sorensen NA, Schwemer T, et al. (Westermann D, senior author).Diagnosis of myocardial infarction using a high-sensitivity troponin I 1-hour algorithm.

    • 2ESC 2015 Late-Breaking Clinical Trial: Accurate and rapid diagnosis of myocardial infarction using a high sensitivity Troponin I 1-hour algorithm. Presented on August 30 by D Westermann. Discussant, J Alpert.

    Biomarkers in Acute Cardiac Carehigh-sensitivity troponinhsTnTMyocardial necrosisNon-ST segment elevation myocardial infarctionNSTEMItroponins

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok